Mechanism
Explored for immune support in aging and oncology patients.
Technical28-aa peptide modulating T-cell maturation and TLR signaling.
Reported uses by species
| Species | Indication | Tier | Honest evidence note |
|---|---|---|---|
| Dogs / Cats | Adjunctive immune support — geriatric / oncology | Investigational | Veterinary interest; controlled species-data limited. |
Suggested starting protocol
Starting points only — clinical judgment required. Dosing unlocks for verified veterinary accounts.
No species-specific starting protocol published. Contact clinical support.
Monitoring, contraindications & do-not-use-if
Investigational. Coordinate with oncology team if used adjunctively.
The evidence
- CIVT veterinary webinarCIVT